Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting tumor microenvironment for non-small cell lung cancer immunotherapy
Lei Wang, Qingzhu Jia, Qian Chu, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 1, pp. 18-29
Open Access | Times Cited: 11

Showing 11 citing articles:

AXL: shapers of tumor progression and immunosuppressive microenvironments
Yihui Liu, Lei Xu, Yuanyao Dou, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect
Conghua Lu, Ziyuan Gao, Di Wu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009165-e009165
Open Access | Times Cited: 10
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
Chengdi Wang, Jingwei Li, Jingyao Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Non-Viral RNA Therapies for Non-Small Cell Lung Cancer and Their Corresponding Clinical Trials
Palas Balakdas Tiwade, Vincent Fung, Rachel VanKeulen-Miller, et al.
Molecular Pharmaceutics (2025)
Closed Access
ATF3 Within the Interferon Signaling Pathway: A Potential Biomarker for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy
Chao He, Rui Han, Taiming Zhang, et al.
Thoracic Cancer (2025) Vol. 16, Iss. 7
Open Access
Resistance in Lung Cancer Immunotherapy and How to Overcome It: Insights from the Genetics Perspective and Combination Therapies Approach
Paweł Zieliński, Maria Stępień, Hanna Chowaniec, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 587-587
Open Access
Mechanistic Insights and Therapeutic Applications of Hinokitiol in Inflammation, Antimicrobial Therapy, and Cancer
Karthik K Karunakar, Binoy Varghese Cheriyan, Ramaiyan Velmurugan, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 13, pp. 100527-100527
Open Access | Times Cited: 1
Recent advances in the treatment of non-small cell lung cancer with MET inhibitors
Dongna Zhang, Wenying Zhang, He Liu, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access
Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion
Qianqian Xue, Wenbei Peng, Siyu Zhang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e010040-e010040
Open Access
Enhancing the Treating Efficacy of Immunotherapy through the Restructure of Tumor Microenvironment
Bokai Gong, Wenfeng Jia, Zhou Yang, et al.
Advanced NanoBiomed Research (2023) Vol. 3, Iss. 12
Open Access
Page 1

Scroll to top